153 related articles for article (PubMed ID: 37858804)
1. Ultrasound targeted microbubble destruction using docetaxel and Rose Bengal loaded Microbubbles for targeted Chemo-Sonodynamic therapy treatment of prostate cancer.
McKaig T; Logan K; Nesbitt H; Callan B; McKeown S; O'Sullivan JM; Kelly P; O'Rourke D; McHale AP; Callan JF
Eur J Pharm Biopharm; 2023 Nov; 192():196-205. PubMed ID: 37858804
[TBL] [Abstract][Full Text] [Related]
2. Targeted chemo-sonodynamic therapy treatment of breast tumours using ultrasound responsive microbubbles loaded with paclitaxel, doxorubicin and Rose Bengal.
Logan K; Foglietta F; Nesbitt H; Sheng Y; McKaig T; Kamila S; Gao J; Nomikou N; Callan B; McHale AP; Callan JF
Eur J Pharm Biopharm; 2019 Jun; 139():224-231. PubMed ID: 30959180
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer.
Nesbitt H; Sheng Y; Kamila S; Logan K; Thomas K; Callan B; Taylor MA; Love M; O'Rourke D; Kelly P; Beguin E; Stride E; McHale AP; Callan JF
J Control Release; 2018 Jun; 279():8-16. PubMed ID: 29653222
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction.
Logan KA; Nesbitt H; Callan B; Gao J; McKaig T; Taylor M; Love M; McHale AP; Callan JF
Eur J Pharm Biopharm; 2021 Aug; 165():374-382. PubMed ID: 34038797
[TBL] [Abstract][Full Text] [Related]
5. Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle.
McEwan C; Kamila S; Owen J; Nesbitt H; Callan B; Borden M; Nomikou N; Hamoudi RA; Taylor MA; Stride E; McHale AP; Callan JF
Biomaterials; 2016 Feb; 80():20-32. PubMed ID: 26702983
[TBL] [Abstract][Full Text] [Related]
6. Ultra-small micelles together with UTMD enhanced the therapeutic effect of docetaxel on Glioblastoma.
Mao K; Jiang Q; Jiang Y; Fu Z; Hu J; Sun H; Mao W
Eur J Pharm Sci; 2023 Aug; 187():106468. PubMed ID: 37220818
[TBL] [Abstract][Full Text] [Related]
7. Target tumor therapy in human gastric cancer cells through the combination of docetaxel-loaded cationic lipid microbubbles and ultrasound-triggered microbubble destruction.
Lai B; Ouyang X; Mao S; Cao J; Li H; Li S; Wang J
Funct Integr Genomics; 2023 Feb; 23(1):59. PubMed ID: 36757623
[TBL] [Abstract][Full Text] [Related]
8. Concise Nanoplatform of Phycocyanin Nanoparticle Loaded with Docetaxel for Synergetic Chemo-sonodynamic Antitumor Therapy.
Cao J; Pan Q; Bei S; Zheng M; Sun Z; Qi X; Shen S
ACS Appl Bio Mater; 2021 Sep; 4(9):7176-7185. PubMed ID: 35006949
[TBL] [Abstract][Full Text] [Related]
9. In situ conversion of rose bengal microbubbles into nanoparticles for ultrasound imaging guided sonodynamic therapy with enhanced antitumor efficacy.
Hou R; Liang X; Li X; Zhang X; Ma X; Wang F
Biomater Sci; 2020 May; 8(9):2526-2536. PubMed ID: 32215400
[TBL] [Abstract][Full Text] [Related]
10. A single microbubble formulation carrying 5-fluorouridine, Irinotecan and oxaliplatin to enable FOLFIRINOX treatment of pancreatic and colon cancer using ultrasound targeted microbubble destruction.
Gao J; Logan KA; Nesbitt H; Callan B; McKaig T; Taylor M; Love M; McHale AP; Griffith DM; Callan JF
J Control Release; 2021 Oct; 338():358-366. PubMed ID: 34481018
[TBL] [Abstract][Full Text] [Related]
11. Docetaxel-loaded lipid microbubbles combined with ultrasound-triggered microbubble destruction for targeted tumor therapy in MHCC-H cells.
Zhang Y; Chang R; Li M; Zhao K; Zheng H; Zhou X
Onco Targets Ther; 2016; 9():4763-71. PubMed ID: 27536139
[TBL] [Abstract][Full Text] [Related]
12. Manipulation of Mitophagy by "All-in-One" nanosensitizer augments sonodynamic glioma therapy.
Qu F; Wang P; Zhang K; Shi Y; Li Y; Li C; Lu J; Liu Q; Wang X
Autophagy; 2020 Aug; 16(8):1413-1435. PubMed ID: 31674265
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Sequential Treatment With Androgen Receptor-Targeted Agent Followed by Another Androgen Receptor-Targeted Agent Versus Androgen Receptor-Targeted Agent Followed by Docetaxel in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer.
Matsubara N; Yamada Y; Tabata KI; Satoh T; Kamiya N; Suzuki H; Kawahara T; Uemura H; Yano A; Kawakami S; Otsuka M; Fukasawa S
Clin Genitourin Cancer; 2017 Dec; 15(6):e1073-e1080. PubMed ID: 28826931
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial.
Fizazi K; Faivre L; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houede N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Chinet-Charrot P; Legouffe E; Lagrange JL; Linassier C; Deplanque G; Beuzeboc P; Davin JL; Martin AL; Habibian M; Laplanche A; Culine S
Lancet Oncol; 2015 Jul; 16(7):787-94. PubMed ID: 26028518
[TBL] [Abstract][Full Text] [Related]
15. Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer.
Sheng Y; Beguin E; Nesbitt H; Kamila S; Owen J; Barnsley LC; Callan B; O'Kane C; Nomikou N; Hamoudi R; Taylor MA; Love M; Kelly P; O'Rourke D; Stride E; McHale AP; Callan JF
J Control Release; 2017 Sep; 262():192-200. PubMed ID: 28764995
[TBL] [Abstract][Full Text] [Related]
16. Addition of Docetaxel to Androgen Receptor Axis-targeted Therapy and Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis.
Roy S; Sayyid R; Saad F; Sun Y; Lajkosz K; Ong M; Klaassen Z; Malone S; Spratt DE; Wallis CJD; Morgan SC
Eur Urol Oncol; 2022 Oct; 5(5):494-502. PubMed ID: 35811293
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting DVDMS-nanoliposomes for an enhanced sonodynamic therapy of gliomas.
Sun Y; Wang H; Wang P; Zhang K; Geng X; Liu Q; Wang X
Biomater Sci; 2019 Feb; 7(3):985-994. PubMed ID: 30601475
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.
Pilling A; Kim SH; Hwang C
Prostate; 2022 Feb; 82(2):182-192. PubMed ID: 34672379
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound Targeted Microbubble Destruction-Mediated Delivery of a Transcription Factor Decoy Inhibits STAT3 Signaling and Tumor Growth.
Kopechek JA; Carson AR; McTiernan CF; Chen X; Hasjim B; Lavery L; Sen M; Grandis JR; Villanueva FS
Theranostics; 2015; 5(12):1378-87. PubMed ID: 26681983
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of localized ultrasound-targeted microbubble destruction with doxorubicin liposomes in H22 mouse hepatocellular carcinoma model.
Zhu F; Jiang Y; Luo F; Li P
J Drug Target; 2015 May; 23(4):323-34. PubMed ID: 25609362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
